MGI(SH:688114) Xin Lang Cai Jing·2026-01-16 03:05Group 1 - The core viewpoint of the news is that BGI Genomics has experienced a significant decline in its stock price, dropping 5.12% on January 16, with a cumulative decline of 8.59% over three consecutive days [1] - As of the report, BGI Genomics' stock price is at 68.32 yuan per share, with a trading volume of 274 million yuan and a turnover rate of 0.95%, resulting in a total market capitalization of 28.456 billion yuan [1] - The company, established on April 13, 2016, and listed on September 9, 2022, focuses on the life sciences and biotechnology sectors, with its main business revenue composition being 90.89% from sales of instruments and consumables, 7.10% from services, and 2.01% from other sources [1] Group 2 - From the perspective of major fund holdings, one fund under ICBC Credit Suisse has a significant position in BGI Genomics, specifically the Sci-Tech Medicine ETF (588860), which reduced its holdings by 10,500 shares in the third quarter, now holding 80,900 shares, accounting for 2.72% of the fund's net value [2] - The estimated floating loss for the fund today is approximately 298,400 yuan, with a total floating loss of 547,500 yuan during the three-day decline [2] - The Sci-Tech Medicine ETF (588860) was established on August 8, 2024, with a current scale of 206 million yuan, and has achieved a year-to-date return of 9.96%, ranking 1057 out of 5531 in its category [2]